the ability of csf-hu ( p-100 ) to inhibit and improve the leukocytopenia and granulocytopenia which occur following cancer chemotherapy was investigated in a double-blind study which included an inactive placebo .
C0023530
leukocytopenia
C0001824
granulocytopenia